Jump to content

Americans for Safe Access v. Drug Enforcement Administration

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bri (talk | contribs) at 05:48, 21 January 2021 (→Further reading: title disagrees with transcript; this is actually Science Friday). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Americans for Safe Access v. Drug Enforcement Administration was a case in which the U.S. Court of Appeals for the D.C. Circuit held that the DEA's denial of a petition by plaintiff Americans for Safe Access for removal of cannabis from Schedule I of the Controlled Substances Act survives review under the deferential arbitrary and capricious standard. 21 U.S.C. § 812(b)(1)(B) requires that cannabis be found to have no "currently accepted medical use" in order to remain in Schedule I. This DEA, pursuant to regulations that the court had approved in Alliance for Cannabis Therapeutics v. DEA, interpreted this to require "adequate and well-controlled studies proving efficacy" in order for cannabis to be removed from Schedule I. The court deferred to the agency's interpretation and found that substantial evidence supported the DEA's determination that such studies do not exist.[1] This case was the third attempt to get the D.C. Circuit to order that cannabis be rescheduled.[2]

Further reading

  • Feds To Debate Marijuana As Medicine (Streaming audio [with transcript]). Science Friday. NPR. October 12, 2012.

References

  1. ^ Americans for Safe Access v. DEA (DC Cir. 2013), Text.
  2. ^ Wishnia, Steven (15 October 2012). "Is marijuana close to being legalized?". Salon.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Americans_for_Safe_Access_v._Drug_Enforcement_Administration&oldid=1001762316"